News

The FDA just approved the SetPoint System, which electrically stimulates the vagus nerve to control inflammation from the ...
SetPoint System, newly approved by the FDA, can ease rheumatoid arthritis symptoms by delivering a small jolt of electricity ...
SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of ...
SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...
The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.
The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.
The small implant helps relieve pain and joint swelling in rheumatoid arthritis and is being investigated for other ...
The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid arthritis.The device is an implantable, integrated neurostimulator about the ...
The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...